(7E)-5-[1-(4-fluorophenyl)ethyl]-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyrazin-6-one;(3E)-1-[1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyridin-2-one
C53H45F2N9O4 — CID 143760316
Data last refreshed: (MolForge compound catalog, from PubChem)
About (7E)-5-[1-(4-fluorophenyl)ethyl]-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyrazin-6-one;(3E)-1-[1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyridin-2-one
(7E)-5-[1-(4-fluorophenyl)ethyl]-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyrazin-6-one;(3E)-1-[1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyridin-2-one (PubChem CID 143760316) has the molecular formula C53H45F2N9O4 and a molecular weight of 910.00 g/mol. Its IUPAC name is (7E)-5-[1-(4-fluorophenyl)ethyl]-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyrazin-6-one;(3E)-1-[1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyridin-2-one.
Molecular Properties
| Compound Name | (7E)-5-[1-(4-fluorophenyl)ethyl]-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyrazin-6-one;(3E)-1-[1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyridin-2-one |
|---|---|
| PubChem CID | 143760316 |
| Molecular Formula | C53H45F2N9O4 |
| Molecular Weight | 910.00 g/mol |
| Exact Mass | 909.36 |
| IUPAC Name | (7E)-5-[1-(4-fluorophenyl)ethyl]-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyrazin-6-one;(3E)-1-[1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]pyrrolo[2,3-b]pyridin-2-one |
| SMILES | COc1cc(/C=C2/C(=O)N(C(C)c3ccc(F)cc3)c3ncccc32)ccc1-n1cnc(C)c1.COc1cc(/C=C2/C(=O)N(C(C)c3ccc(F)cc3)c3nccnc32)ccc1-n1cnc(C)c1 |
| InChI | InChI=1S/C27H23FN4O2.C26H22FN5O2/c1-17-15-31(16-30-17)24-11-6-19(14-25(24)34-3)13-23-22-5-4-12-29-26(22)32(27(23)33)18(2)20-7-9-21(28)10-8-20;1-16-14-31(15-30-16)22-9-4-18(13-23(22)34-3)12-21-24-25(29-11-10-28-24)32(26(21)33)17(2)19-5-7-20(27)8-6-19/h4-16,18H,1-3H3;4-15,17H,1-3H3/b23-13+;21-12+ |
| InChIKey | DINUYOGTLDOXOQ-MSWOKDKPSA-N |
| XLogP | 10.14 |
| TPSA | 133.39 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 68 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 910.00 |
| LogP ≤ 5 | 10.14 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143760316 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.